2013
DOI: 10.1016/j.ijpharm.2012.10.033
|View full text |Cite
|
Sign up to set email alerts
|

Quillaja saponaria extract as mucosal adjuvant with chitosan functionalized gold nanoparticles for mucosal vaccine delivery: Stability and immunoefficiency studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
36
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
6
4

Relationship

1
9

Authors

Journals

citations
Cited by 48 publications
(36 citation statements)
references
References 34 publications
0
36
0
Order By: Relevance
“…Particulate adjuvants such as microspheres, nano-or microparticles, and various polymers used to encapsulate antigens, have been used as carriers or adjuvants for mucosal vaccines, but will not be further discussed in this chapter. The reader is referred to articles on the mucosal application of particulate adjuvants (Jaganathan and Vyas, 2006;Barhate et al, 2013;Slutter et al, 2009); see also Chapter 64.…”
Section: Introductionmentioning
confidence: 99%
“…Particulate adjuvants such as microspheres, nano-or microparticles, and various polymers used to encapsulate antigens, have been used as carriers or adjuvants for mucosal vaccines, but will not be further discussed in this chapter. The reader is referred to articles on the mucosal application of particulate adjuvants (Jaganathan and Vyas, 2006;Barhate et al, 2013;Slutter et al, 2009); see also Chapter 64.…”
Section: Introductionmentioning
confidence: 99%
“…The tree has been used extensively for extraction of saponins, which are high molecular weight glycosides containing a hydrophobic triterpenic nucleus and two hydrophilic sugar chains (Nord and Kenne 1999;San Martín 2000). Q. saponaria saponins have been traditionally used in various industries, such as biopesticides and plant growth stimulant in agriculture (Chapagain et al 2007;Fischer et al 2011;Zúñiga et al 2012), emulsifier and foaming agent for animal and human food and beverage (Yang et al 2013), wetting agent in film production and mining (San Martín et al 2005a, b), and as vaccine adjuvants for human and non-human animals vaccines (Barhate et al 2013;Harrer et al 2014;Kensil et al 1991;Kensil and Kammer 1998;Sun et al 2009). …”
mentioning
confidence: 99%
“…The surface morphology and particle size of inorganic NPs can be finely tuned to provide better colloidal stability, high antigen encapsulation efficiency and targeted delivery by attaching ligands [31,116]. The surfaces of inorganic NPs are rigid and stable allowing protection of adsorbed antigens against the harsh GI conditions and preventing premature release of antigens.…”
Section: Inorganic Npsmentioning
confidence: 99%